Antoni Wiedlocha funded by the EEA Poland-Norway grants
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Edwin TH, Håberg AK, Zotcheva E, Bratsberg B, Jugessur A, Engdahl B, Bowen C, Selbæk G, Kohler HP, Harris JR, Tom SE, Krokstad S, Mekonnen T, Stern Y, Skirbekk VF, Strand BH(2024) Trajectories of Occupational Cognitive Demands and Risk of Mild Cognitive Impairment and Dementia in Later Life: The HUNT4 70+ Study Neurology, 102(9), e209353 DOI 10.1212/WNL.0000000000209353, PubMed 38630959
Lång E, Lång A, Blicher P, Rognes T, Dommersnes PG, Bøe SO(2024) Topology-guided polar ordering of collective cell migration Sci Adv, 10(16), eadk4825 DOI 10.1126/sciadv.adk4825, PubMed 38630812
Toft M(2024) New gene involved in the pathogenesis of Parkinson's disease Lancet Neurol(in press) DOI 10.1016/S1474-4422(24)00166-2, PubMed 38614109